CryoPort (CYRX) vs Rigel Pharmaceuticals (RIGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
CryoPort (CYRX) has outperformed Rigel Pharmaceuticals (RIGL) over the past year, gaining 77.0% versus a gain of 62.7%. Over five years, RIGL leads with a +42.0% price change compared with -75.3% for CYRX. Rigel Pharmaceuticals is the larger company by market cap ($896.4 million vs $878.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYRX | RIGL |
|---|---|---|
| Share price | $17.35 | $47.99 |
| Market cap | $878.76M | $896.45M |
| 1-day change | -2.53% | +4.08% |
| YTD return | +80.73% | +12.05% |
| 1-year return | +77.04% | +62.68% |
| 5-year return | -75.31% | +41.98% |
| P/E ratio (TTM) | — | 2.84 |
| Forward P/E | — | 9.72 |
| EPS (TTM) | $-0.81 | $16.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.36 | $52.24 |
| 52-week low | $7.61 | $24.95 |
| Distance from 52-week high | -5.50% | -8.14% |
| Average volume | 620.99K | 291.58K |
| Shares outstanding | 50.65M | 18.68M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CYRX has outperformed RIGL by 14.4 percentage points over the past year.
CYRX vs RIGL FAQ
Which is bigger, CryoPort or Rigel Pharmaceuticals?
Rigel Pharmaceuticals (RIGL) is larger, with a market capitalization of $896.45M compared with $878.76M for CryoPort (CYRX).
Which stock has performed better over the past year, CYRX or RIGL?
CYRX returned +77.04% over the past 12 months, compared with +62.68% for RIGL (price return, excluding dividends). Past performance does not predict future results.
Are CryoPort and Rigel Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.